Boris G. Wilson
GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Chromatin Remodeling and Cancer, Cancer Mechanisms and Therapy, Genomics and Chromatin Dynamics, Protein Degradation and Inhibitors, Epigenetics and DNA Methylation
Most-Cited Works
- → SWI/SNF nucleosome remodellers and cancer(2011)1,267 cited
- → Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation(2010)636 cited
- → ARID1B is a specific vulnerability in ARID1A-mutant cancers(2014)422 cited
- → Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers(2014)409 cited
- → ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice(2016)370 cited
- → Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway(2010)252 cited
- → Residual Complexes Containing SMARCA2 (BRM) Underlie the Oncogenic Drive of SMARCA4 (BRG1) Mutation(2014)231 cited
- → Swi/Snf chromatin remodeling/tumor suppressor complex establishes nucleosome occupancy at target promoters(2013)192 cited
- → The Genome-Wide Localization of Rsc9, a Component of the RSC Chromatin-Remodeling Complex, Changes in Response to Stress(2002)145 cited
- → Dephosphorylation and Genome-Wide Association of Maf1 with Pol III-Transcribed Genes during Repression(2006)133 cited